TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Lower placental edge thickness measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in height standard deviation scores (HT SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Positive and Negative Syndrome Scale- Excited Component (PEC) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum nicotine blood level (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to maximum blood level (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-Readiness for Skin Graft in Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: HAMD-24 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Temporomandibular Joint Functional Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of 46,XY DSD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMS/EGS (External Masculinization Score and External Genital Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age of onset of genital ambiguity signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 year Progression Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: QoR-40 scale score at 24 hours after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: QoR-40 scale score at 48 hours after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent of Risky Decisions with stimulation on
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent of Risky Decisions with stimulation off
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of participants with common adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: 28-day survival improvement
Endpoint domain: Mortality/survival
Primary endpoint: Number of MRI scans used to detect clinically significant PCs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinically significant PC diagnoses compared to benign biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinically significant PC diagnoses compared to clinically insignificant PC diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Count of participants with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Variation of averaged intensity of craving episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival at 18 weeks
Endpoint domain: Mortality/survival
Primary endpoint: AUClast of budesonide and albuterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of budesonide and albuterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of budesonide and albuterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of bone mineral density (BMD) decline at the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in EuroQol-5 Dimension - 5 levels (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in poverty probability index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prediction of hypotension episode (HPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systemic Vascular resistance (SVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Event Rate of Device Success (VARC-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Free of pacemaker implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Free of new onset complete left bundle branch block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Catheter-associated Thrombosis (CAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of patients hospitalized or with extended hospitalization for COVID-19 complications
Endpoint domain: Mortality/survival
Primary endpoint: Kujala pain Rating score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life Scale QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline in Quality of Life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Grade 4 or higher signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: SARS-CoV-2 case detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent Change in CSF cGMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of delirium after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of Neo-DCVac combined with ICIs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Parent Reported Socialization
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in soluble transferrin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Temperature maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature minimum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time without using alcohol
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Penetration-Aspiration Score (PAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to perform transanal irrigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Amplitude of Center of Pressure under simple conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of Center of Pressure under Dual Task conditions (Motor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trail-Making Test
Endpoint domain: Cognitive functioning
Primary endpoint: Change in number of migraine attacks per 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcomes following surgical debridement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Depression symptom ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety and depressive symptoms at T1 - caregiver report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety and depressive symptoms at T1 - child/adolescent report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CSF Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: intracellular zinc status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net difference in mean change of systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cognition of NPS
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients with haemorrhagic or thrombotic event
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal endothelial changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants discontinuing study intervention due to an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep Onset Latency Measured by the Maintenance of Wakefulness Test (MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: time to active delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in microvascular blood flow response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in microvascular endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Alcohol Use Disorder Identification Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinical Institute Withdrawal Assessment for Alcohol-Revised score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Penn Alcohol Craving Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency use for bronchiolitis
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Brainstem activation pattern on fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional connectivity pattern of nucleus tractus solitarii on fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional connectivity pattern of locus coeruleus on fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in emotional well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Overall Well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Burnout
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Anxiety Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in cognitive control scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevention coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants with viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of participants with hypertension control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUROC for Classification of Admission to General Ward
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC for Classification of Admission to Intensive Care Unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC for Classification of 30 Day Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Aneurysmal subarachnoid hemorrhage related secondary brain injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Biomarkers of acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Cognition in Stroop inhibition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in sick leave patterns
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Explicit Memory Bias
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: The Arabic Version Of Neck Disability Index (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of Nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Aldrete Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psoriatic Area and Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Myer Assessment upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Evaluation Scale for Upper Extremity in Stroke patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional status and habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Disease activity of the patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TTP
Endpoint domain: Mortality/survival
Primary endpoint: Morbidity of TTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality of TTP
Endpoint domain: Mortality/survival
Primary endpoint: Severity of hip pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional Throwing Performance Index (FTPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with Sputum Culture Negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of 2X-121 monotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of dovitinib in combination with 2X-121
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriate intrauterine development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional binding availability and volume of distribution of Mu-Opioid receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional binding availability and volume of distribution of Kappa-Opioid receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurogenic Bowel Dysfunction Score (NBDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: defaecation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Angles of the subject's joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Activities of muscles state of human movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehensive intention of the subjects
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Area under the concentration-time curve from time zero extrapolated to infinite time (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from time zero to the time of the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Amphetamine-type Stimulant Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Second Sit-to-Stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Solicited Local (Injection Site) Adverse Events (AEs) Within 7 Days Post Vaccination at Day 1
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Solicited Systemic AEs Within 14 Days Post Vaccination at Day 1
Endpoint domain: Adverse events/effects
Primary endpoint: Depression (PHQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Monocular navigation performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of individuals free from Erythema Nodosum Leprosum (ENL) flares in 24 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of individuals free from Erythema Nodosum Leprosum (ENL) flares in 48 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Blood concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ELF concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of sentinel lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to achieve hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of phoneme decoding accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in speaking
Endpoint domain: Life impact
Endpoint subdomain: Communication functioning
Primary endpoint: Total score of Parkinson's Disease Sleep Scale - version 2 (PDSS-2)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improvement in Diabetic Retinopathy Severity Scale (DRSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Metabolomic profile analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum morbidity and mortality at hospital discharge
Endpoint domain: Mortality/survival
Primary endpoint: Postpartum morbidity and mortality at 30 days postpartum
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients without amputations
Endpoint domain: Mortality/survival
Primary endpoint: Chronic Graft-versus-Host-Disease-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: 30-second chair-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tandem Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High on-treatment platelet reactivity (HTPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of sympathetic plexus injury
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of postoperative emergence delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Biochemically verified tobacco-use cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Light Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedentary Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of PS score change from 2~4 to 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum diaphragm thickness during phrenic nerve repetitive stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in diaphragm thickness before and during phrenic nerve repetitive stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in treatment adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change in fluid control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Objective Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in autonomic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-Year Overall Survival
Endpoint domain: Mortality/survival
Primary endpoint: Urinary ketone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FEV1 AUC (0-8h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Baseline Skin Features (pores, wrinkles, colour, pigmentation and redness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline Superficial Hydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline Skin Barrier Integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Identification of Non-gal, non-HLA protein antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local pelvic recurrence
Endpoint domain: Mortality/survival
Primary endpoint: arterial PO2/FiO2 Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Statin Prescription
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Repeatability of NT-proBNP and BNP samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of NT-proBNP test with pre-processing time delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of exercise testing on NT-proBNP and BNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical manifestation of functional constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Relative rehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Protective Behavioral Strategies for Marijuana (PBSM-17) used
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in alcohol abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test Of Sensory Functions In Infants (TSFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peabody Developmental Motor Scales-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance measured by SSRT
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in quality of vaginal discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes